ArticleBiology direct2019

MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway.

Mei Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.